Mario Chojkier

A First in Class Treatment for Liver Cirrhosis

National Institute of Diabetes and Digestive and Kidney Diseases · R44

PI · $2.5M · Xfibra, Inc.

An Agnostic, Host-Direct Survival Cure MCM for Pulmonary Toxicants.

National Institute of Allergy and Infectious Diseases · R44

PI · $999.6K · Xfibra, Inc.

Treatment of Lung Fibrosis : Ind Pharmacology and Toxicology

National Heart, Lung, and Blood Institute · R44

PI · $1.6M · Xfibra, Inc.

Targeting C/EBP-Beta Phosphorylation for the Treatment of Lung Fibrosis

National Heart, Lung, and Blood Institute · R41

Contact PI · $316.1K · Xfibra, Inc.

Effects of Vitamin D on Inflammation in Liver Disease

Principal investigator · Unknown · Phase 2

Veterans Medical Research Foundation

Study the Relationship Between Obesity and Hepatitis C Replication

Principal investigator · Withdrawn · Phase 2

University of California, San Diego

A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity

Principal investigator · Suspended · Phase 2

University of California, San Diego